Half yearly and year to date results of the Company for the half year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 2.5 pts more than its Waste Management peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
EP Biocomposites Limited submitted its audited half-yearly results for the period ended March 31, 2025 at a board meeting held on May 23, 2025. For the half year ended March 31, 2025, revenue from operations surged to ₹760.13 lakhs from ₹440.49 lakhs in the previous corresponding half year (around 72% growth), while profit after tax jumped to ₹82.53 lakhs from ₹20.55 lakhs (roughly fourfold increase). For the full financial year FY25, revenue grew modestly to ₹1,200.62 lakhs from ₹1,143.92 lakhs, but profit after tax dipped slightly to ₹103.08 lakhs from ₹114.97 lakhs, and EPS fell to ₹6.13 from ₹6.84. Statutory auditor S.P. Bhandare & Associates issued an unqualified opinion, stating the results give a true and fair view, with no going concern or emphasis of matter flagged. The company confirmed full utilization of its ₹580.04 lakh net IPO proceeds toward lease deposits, loan repayment, working capital, and general corporate purposes.
The sharp half-yearly jump in revenue and profits is positive for shareholders, suggesting strong operational momentum in H2 FY25, though full-year PAT was slightly lower year-on-year and EPS dipped. The clean auditor report and full deployment of IPO funds remove overhang concerns.